Journal of Renal Nutrition
Volume 20, Issue 4 , Pages 255-262 , July 2010

Adiponectin, Resistin and Leptin Response to Dietary Intervention in Diabetic Nephropathy

  • Lucyna Kozłowska, PhD

      Affiliations

    • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences, Warsaw, Poland
    • Corresponding Author InformationAddress reprint requests to Lucyna Kozłowska, Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland.
    • ,
  • Andrzej Rydzewski, MD, PhD

      Affiliations

    • Department of Internal Medicine and Nephrology, Central Clinical Hospital of The Ministry of Internal Affairs and Administration, Warsaw, Poland
    • Institute of Medical Education, Jan Kochanowski University, Kielce, Poland
    • ,
  • Bartosz Fiderkiewicz, MD

      Affiliations

    • Department of Internal Medicine and Nephrology, Central Clinical Hospital of The Ministry of Internal Affairs and Administration, Warsaw, Poland
    • ,
  • Anna Wasińska-Krawczyk, MD

      Affiliations

    • Department of Internal Medicine and Nephrology, Central Clinical Hospital of The Ministry of Internal Affairs and Administration, Warsaw, Poland
    • ,
  • Agnieszka Grzechnik

      Affiliations

    • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences, Warsaw, Poland
    • ,
  • Danuta Rosołowska-Huszcz, PhD

      Affiliations

    • Department of Dietetics, Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences, Warsaw, Poland

References 

  1. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  2. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in adiposity. J Biol Chem. 1996;271:10697–10703
  3. Statnick MA, Beavers LS, Conner LJ, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diab Res. 2000;1:81–88
  4. Yamauchi T, Kamon J, Waki H, et al. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–946
  5. Ouchi N, Kihara Y, Arita Y, et al. Adiponectin, an adipocyte derived plasma protein inhibits endothelial NF-κB signaling through a cAMP dependent pathway. Circulation. 2000;102:1296–1301
  6. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein, adiponectin. Circulation. 1999;100:2473–2476
  7. Zhang JL, Qin YW, Zheng X, et al. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med. 2003;20:828–831
  8. Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest. 2007;67:215–225
  9. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149:331–335
  10. Osawa H, Ochi M, Kato K, et al. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes. Biochem Biophys Res Commun. 2007;355:342–346
  11. Shimomura J, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999;401:73–76
  12. Lee JH, Reed DR, Price RA. Leptin resistance is associated with extreme obesity and aggregates in families. Int J Obes Relat Metab Disord. 2001;25:1471–1473
  13. Maedler K, Schulthess FT, Bielman C, et al. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J. 2008;22:1905–1913
  14. Saito T, Saito O, Kawano T, et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabet Res Clin Pract. 2007;78:85–92
  15. Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabet Care. 2007;30:239–244
  16. Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006;69:596–604
  17. Menon V, Wang X, Greene T, et al. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol. 2004;61:163–169
  18. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron. 2001;89:348–349
  19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;16:461–470
  20. Yannakoulia M, Yiannakouris N, Bluher S, et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab. 2003;88:1730–1736
  21. Schaffler A, Buchler C, Muller-Landner U, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res. 2004;36:702–707
  22. Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent antiinflammatory properties. J Immunol. 2005;174:5789–5795
  23. Nagayev S, Bokarewa M, Tarkowski A, et al: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE, e31:1–9, 2006
  24. Axelsson J, Møller HJ, Witasp A, et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis. 2006;48(6):916–925
  25. Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diab Rep. 2006;6(6):463–468
  26. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658
  27. Bergström J, Lindholm B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am J Kidney Dis. 1998;32(5):834–841
  28. Balage M, Averous J, Rémond D, et al. Presence of low-grade inflammation impaired postprandial stimulation of muscle protein synthesis in old rats. J Nutr Biochem. 2009;13:
  29. Rieu I, Magne H, Savary-Auzeloux I, et al. Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol Sep. 2009;14:
  30. Bottner A, Kratzsch J, Muller G, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004;89:4053–4061
  31. Couillard C, Mauriege P, Prud'homme D, et al. Plasma leptin concentrations: gender differences and associations with met abolic risk factors for cardiovascular disease. Diabetologia. 1997;40:1178–1184
  32. Isobe T, Saitoh S, Takagi S, et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol. 2005;153:91–98
  33. Isidori AM, Strollo F, More M. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab. 2000;85:1954–1962
  34. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–1935
  35. Lu HL, Wang HW, Zhang MX, et al. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol. 2006;12:1747–1751
  36. Ryan AS, Nicklas BJ, Berman DM, et al. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord. 2003;27:1066–1071
  37. Giannopoulou I, Fernhall B, Carhart R, et al. Effects of diet and /or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism. 2005;54:866–875
  38. Abbasi F, Lamendola C, McLaughlin T, et al. Plasma adiponectin concentration do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism. 2004;53:280–283
  39. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increase plasma levels of an adipose derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–3819
  40. Faraj M, Havel PJ, Phelis S, et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–1602
  41. Kozłowska L, Rosołowska-Huszcz D. Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit. Endocrine. 2004;24:147–153
  42. Polson DA, Thompson MP. Macronutrient composition of the diet differentially affects leptin and adiponutrin mRNA expression in response to meal feeding. J Nutr Biochem. 2004;15:242–246
  43. Santoro D. Low-protein diet and proteinuria. G Ital Nefrol. 2008;25:18–24
  44. Kozłowska L, Rosołowska-Huszcz D, Rydzewski A. Low protein diet causes a decrease in serum concentrations of leptin and tumour necrosis factor-alpha in patients with conservatively treated chronic renal failure. Nephrology (Carlton). 2004;9:319–324

PII: S1051-2276(10)00010-5

doi: 10.1053/j.jrn.2010.01.009

Journal of Renal Nutrition
Volume 20, Issue 4 , Pages 255-262 , July 2010

Article Tools

* Image Usage & Resolution